Eurofins Amar Immunodiagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-07-2024
- Paid Up Capital ₹ 0.83 M
as on 04-07-2024
- Company Age 23 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.80 M
as on 04-07-2024
- Revenue 13.51%
(FY 2023)
- Profit -93.28%
(FY 2023)
- Ebitda -64.66%
(FY 2023)
- Net Worth 1.12%
(FY 2023)
- Total Assets 43.20%
(FY 2023)
About Eurofins Amar Immunodiagnostics
The Corporate was formerly known as Eurofins Amar Immunodiagnostics Private Limited. The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.83 M.
The company has closed loans amounting to ₹4.80 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Neeraj Garg and Ajay Singh serve as directors at the Company.
- CIN/LLPIN
U33112KA2001PTC153589
- Company No.
099635
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Eurofins Amar Immunodiagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Garg  | Director | 19-Oct-2020 | Current |
| Ajay Singh | Director | 27-Feb-2023 | Current |
Financial Performance and Corporate Structure Insights of Eurofins Amar Immunodiagnostics.
Eurofins Amar Immunodiagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.51% increase. The company also saw a substantial fall in profitability, with a 93.28% decrease in profit. The company's net worth moved up by a moderate rise of 1.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eurofins Amar Immunodiagnostics?
In 2023, Eurofins Amar Immunodiagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eurofins Advinus Biopharma Services India Private LimitedActive 6 years 1 monthNeeraj Garg is a mutual person
- Eurofins Advinus Discovery Services Private LimitedActive 5 years 9 months
Neeraj Garg is a mutual person
Eurofins Clinical Diagnostics Bangalore Private LimitedActive 9 years 9 daysNeeraj Garg is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 09 Jan 2017 | ₹1.80 M | Satisfied |
Department Of Biotechnology Creation Date: 21 Apr 2010 | ₹3.00 M | Satisfied |
How Many Employees Work at Eurofins Amar Immunodiagnostics?
Eurofins Amar Immunodiagnostics has a workforce of 14 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eurofins Amar Immunodiagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eurofins Amar Immunodiagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
